Skip to content

Sacrospinous Ligament Fixation vs Ischial Spine Fascia Fixation

A Prospective, Randomized Comparison of Efficacy and Effect on Quality of Life Between Sacrospinous Ligament Fixation and Ischial Spine Fascia Fixation

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03005613
Enrollment
76
Registered
2016-12-29
Start date
2017-01-15
Completion date
2023-02-01
Last updated
2026-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urogenital Prolapse

Keywords

Pelvic organ prolapse, Sacrospinous ligament fixation, Ischial spine fascia fixation, Clinical outcome

Brief summary

A Prospective, Randomized Comparison of Efficacy and Effect on Quality of Life Between Sacrospinous Ligament Fixation and Ischial Spine Fascia Fixation.

Detailed description

Investigational intervention:SSLF or ISFF operations Study title:A Prospective, Randomized Comparison of Efficacy and Effect on Quality of Life Between Sacrospinous Ligament Fixation and Ischial Spine Fascia Fixation. Principal Investigator:Chang Ren, M.D., Department of Obstetrics & Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College. Study subjects:Adult patients with symptomatic stage II\ IV pelvic organ prolapse will be eligible if all the inclusion criteria are met and without any reason for exclusion. Study objectives:The primary objective of this study is to assess the short and mid-term efficacy of Sacrospinous Ligament Fixation and Ischial Spine Fascia Fixation in treating stage II\ IV pelvic organ prolapse and their recurrence rate as well as their impacts on quality of life. Study design:Prospective, Single-Blind, Randomized, Clinical Trial Intervention: * ISFF group:Patients receive ISFF according to randomization. * SSLF group:Patients receive SSLF according to randomization Sample size:76 patients (38 in ISFF group, 38 in SSLF group) Primary endpoint: •objective success rates at 3 months after operations. Secondary endpoints: * peri-operative parameters . * subjective satisfactory rates at 1 year after operations * quality of life questionnaires at 1 year after operations Safety endpoints: complications

Interventions

PROCEDUREischial spine fascia fixation

The participants will receive ischial spine fascia fixation.

The participants will receive sacrospinous ligament fixation.

Sponsors

Peking Union Medical College Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* age≤65 years, for those scheduled to receive hysterectomy age≥40 years * patients with symptomatic stage II\~IV uterine or vaginal vault prolapse * receiving SSLF or ISFF in the gynecological department at Peking Union Medical College Hospital

Exclusion criteria

* plans to live abroad within follow-up span * contradiction to these two operations: acute genital infection, narrow vagina (less than two finger-breadth), too-ill to receive operations * patients with hip joint problem who could not pose a lithotomy position

Design outcomes

Primary

MeasureTime frameDescription
objective success3 months after operationno prolapse, stage I or only asymptomatic stage II prolapse

Secondary

MeasureTime frameDescription
Pelvic Floor Distress Inventory-20 (PFDI-20)Change from Baseline in PFDI-20 at 3 months and 1 yearto evaluate the quality of life in 3 domains
subjective satisfaction ( according to a scale of 5 degrees: significantly worse, worse, no change, improved, greatly improved)1 year after operationPatient's response as improved or greatly improved
Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire-12 (PISQ-12)Change from Baseline in PISQ-12 at 3 months and 1 yearto evaluate the sexual function
complicationsthrough study completion, an average of 1 yearperi-operative:massive bleeding, organ injury; post-operative: pelvic hematoma, pain, de novo UI, de novo dyspareunia
recurrence rate3 months after operationmore than asymptomatic stage II prolapse after 3 months
Pelvic Floor Impact Questionnaire-7 (PFIQ-7)Change from Baseline in PFIQ-7 at 3 months and 1 yearto evaluate the quality of life in 3 domains

Countries

China

Contacts

PRINCIPAL_INVESTIGATORChang Ren, M.D.

Peking Union Medical College Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026